In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Insulet closes $50mm financing round

Executive Summary

Diabetes management company Insulet brought in $50mm through a private financing led by first-time investor OrbiMed Advisors. Other new backer Federated Kaufman Fund was joined by returning shareholders Alta Partners, Pequot Ventures, Prism Venture Partners, Schroeder Ventures Life Sciences, and Versant Ventures. The company has developed the OmniPod insulin delivery system that incorporates the handheld Personal Diabetes Manager to measure blood glucose levels using a single device.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Medical Devices
    • Infusion Therapy Equipment and Supplies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies